Cantuaria G - Search Results

1

Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer.

Vergote I, Ray-Coquard I, Anderson DM, Cantuaria G, Colombo N, Garnier-Tixidre C, Gilbert L, Harter P, Hettle R, Lorusso D, Mäenpää J, Marth C, Matsumoto K, Ouwens M, Poveda A, Raspagliesi F, Rhodes K, Rubio Pérez MJ, Shapira-Frommer R, Shikama A, Sikorska M, Moore K, DiSilvestro P. Vergote I, et al. Among authors: cantuaria g. Eur J Cancer. 2021 Nov;157:415-423. doi: 10.1016/j.ejca.2021.08.023. Epub 2021 Sep 28. Eur J Cancer. 2021. PMID: 34597975 Free article. Clinical Trial.

2

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, Mannel R, Shahin MS, Cantuaria GH, Girda E, Mathews C, Kavecansky J, Leath CA 3rd, Gien LT, Hinchcliff EM, Lele SB, Landrum LM, Backes F, O'Cearbhaill RE, Al Baghdadi T, Hill EK, Thaker PH, John VS, Welch S, Fader AN, Powell MA, Aghajanian C. Eskander RN, et al. Among authors: cantuaria gh. N Engl J Med. 2023 Jun 8;388(23):2159-2170. doi: 10.1056/NEJMoa2302312. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972022 Free PMC article. Clinical Trial.

3

Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations.

Wright N, Xia J, Cantuaria G, Klimov S, Jones M, Neema P, Il'yasova D, Krishnamurti U, Li X, Reid MD, Gupta M, Rida PC, Osan R, Aneja R. Wright N, et al. Among authors: cantuaria g. PLoS One. 2017 Jan 13;12(1):e0170095. doi: 10.1371/journal.pone.0170095. eCollection 2017. PLoS One. 2017. PMID: 28085947 Free PMC article.

4

KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries.

Pawar S, Donthamsetty S, Pannu V, Rida P, Ogden A, Bowen N, Osan R, Cantuaria G, Aneja R. Pawar S, et al. Among authors: cantuaria g. J Ovarian Res. 2014 May 12;7:53. doi: 10.1186/1757-2215-7-53. eCollection 2014. J Ovarian Res. 2014. PMID: 25028599 Free PMC article.

5

Modulation of cytochrome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics.

Mukkavilli R, Gundala SR, Yang C, Donthamsetty S, Cantuaria G, Jadhav GR, Vangala S, Reid MD, Aneja R. Mukkavilli R, et al. Among authors: cantuaria g. PLoS One. 2014 Sep 24;9(9):e108386. doi: 10.1371/journal.pone.0108386. eCollection 2014. PLoS One. 2014. PMID: 25251219 Free PMC article.

6

Centrosome-declustering drugs mediate a two-pronged attack on interphase and mitosis in supercentrosomal cancer cells.

Pannu V, Rida PC, Celik B, Turaga RC, Ogden A, Cantuaria G, Gopalakrishnan J, Aneja R. Pannu V, et al. Among authors: cantuaria g. Cell Death Dis. 2014 Nov 20;5(11):e1538. doi: 10.1038/cddis.2014.505. Cell Death Dis. 2014. PMID: 25412316 Free PMC article.

7

HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients.

Pannu V, Rida PC, Ogden A, Turaga RC, Donthamsetty S, Bowen NJ, Rudd K, Gupta MV, Reid MD, Cantuaria G, Walczak CE, Aneja R. Pannu V, et al. Among authors: cantuaria g. Oncotarget. 2015 Mar 20;6(8):6076-91. doi: 10.18632/oncotarget.3475. Oncotarget. 2015. PMID: 25788277 Free PMC article.

8

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers.

Pannu V, Mittal K, Cantuaria G, Reid MD, Li X, Donthamsetty S, McBride M, Klimov S, Osan R, Gupta MV, Rida PC, Aneja R. Pannu V, et al. Among authors: cantuaria g. Oncotarget. 2015 Apr 30;6(12):10487-97. doi: 10.18632/oncotarget.3402. Oncotarget. 2015. PMID: 25868856 Free PMC article.

9

How to be good at being bad: centrosome amplification and mitotic propensity drive intratumoral heterogeneity.

Rida PC, Cantuaria G, Reid MD, Kucuk O, Aneja R. Rida PC, et al. Among authors: cantuaria g. Cancer Metastasis Rev. 2015 Dec;34(4):703-13. doi: 10.1007/s10555-015-9590-0. Cancer Metastasis Rev. 2015. PMID: 26358854 Free PMC article. Review.

10

A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas.

Mittal K, Choi DH, Klimov S, Pawar S, Kaur R, Mitra AK, Gupta MV, Sams R, Cantuaria G, Rida PCG, Aneja R. Mittal K, et al. Among authors: cantuaria g. J Ovarian Res. 2016 Mar 18;9:17. doi: 10.1186/s13048-016-0224-0. J Ovarian Res. 2016. PMID: 26992853 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page